Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00216164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell
ClinicalTrials.gov study NCT06806033. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06624085. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT06445517. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas
ClinicalTrials.gov study NCT01788189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02474550. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT07240974. IPD Sharing: NO. Countries: 1. Publications: 0.
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT03837873. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
ClinicalTrials.gov study NCT06863441. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06395870. IPD Sharing: NO. Countries: 1. Publications: 0.
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
ClinicalTrials.gov study NCT05020678. IPD Sharing: NO. Countries: 2. Publications: 0.
Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia
ClinicalTrials.gov study NCT05340829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
ClinicalTrials.gov study NCT02875002. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas
ClinicalTrials.gov study NCT02395601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab Era
ClinicalTrials.gov study NCT04624971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04161118. IPD Sharing: NO. Countries: 1. Publications: 0.
A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
ClinicalTrials.gov study NCT07335120. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05621096. IPD Sharing: NO. Countries: 1. Publications: 0.
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
ClinicalTrials.gov study NCT04099966. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
ClinicalTrials.gov study NCT06615193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.